
Qualified patients may receive chemotherapy under government-backed health programs with no direct payment.
A chemotherapy center in Taguig is now offering free treatment for qualified patients, expanding access to cancer care in a country where the cost of long-term therapy continues to push many patients to delay or stop treatment.
The Taguig Chemotherapy Center said indigent Taguig residents who are PhilHealth members may avail of free chemotherapy sessions, with treatment costs covered through PhilHealth and government assistance programs including Cancer Assistance Fund and local government support. The facility said eligible patients will not shoulder out-of-pocket expenses.
Many patients discontinue or postpone treatment due to financial constraints, a factor that can disrupt care schedules and affect treatment continuity over time.
The center said it covers all cancer types and stages, with no set limit on chemotherapy sessions under available public health support. It can accommodate 40 to 60 patients daily and provides oncology consultations, laboratory and diagnostic services, patient education, and wellness programs for cancer patients.
Patients may register online or walk in for inquiries. Requirements include a valid ID and PhilHealth Member Data Record.
The center is operated by We Hope Medical Group, which said it currently runs around 30 healthcare facilities nationwide and is targeting 100 centers by year-end, with operations across Metro Manila, CALABARZON, Bicol, and Pampanga, and expansion plans in Visayas and Mindanao.
Cancer remains the second leading cause of death in the Philippines, accounting for about 11% of total deaths based on Philippine Statistics Authority provisional data in 2025 reporting periods.
READ:
Rare life-saving brain clot treatment now available at UST
Nikko Miguel Garcia
May 24, 2026
MindCare Club on building telemental healthcare in the Philippines
John Lloyd Aleta
March 16, 2026
VAT-free medicines expanded to 2,263 drugs, easing healthcare costs for Filipinos on long-term treatment
Kenneth M. del Rosario
April 14, 2026
